Hyperglycemia alters PI3k and Akt signaling and leads to endothelial cell proliferative dysfunction.

PubWeight™: 1.94‹?› | Rank: Top 3%

🔗 View Article (PMC 1618822)

Published in Am J Physiol Heart Circ Physiol on June 17, 2005

Authors

Shubha Varma1, Brajesh K Lal, Ruifang Zheng, Jerome W Breslin, Satoshi Saito, Peter J Pappas, Robert W Hobson, Walter N Durán

Author Affiliations

1: Department of Surgery, UMDNJ-New Jersey Medical School, 185 S. Orange Ave., Newark, NJ 07101, USA.

Articles citing this

Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. Curr Neurovasc Res (2007) 1.48

High glucose promotes retinal endothelial cell migration through activation of Src, PI3K/Akt1/eNOS, and ERKs. Am J Physiol Cell Physiol (2008) 1.41

Mechanistic insights into diabetes mellitus and oxidative stress. Curr Med Chem (2007) 1.25

Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies. Prog Neurobiol (2008) 1.13

Insulin-like growth factor-I stimulates Shc-dependent phosphatidylinositol 3-kinase activation via Grb2-associated p85 in vascular smooth muscle cells. J Biol Chem (2008) 1.08

Protective role of morin, a flavonoid, against high glucose induced oxidative stress mediated apoptosis in primary rat hepatocytes. PLoS One (2012) 1.02

Differential healing after sirolimus, paclitaxel, and bare metal stent placement in combination with peroxisome proliferator-activator receptor gamma agonists: requirement for mTOR/Akt2 in PPARgamma activation. Circ Res (2009) 1.01

High glucose induces human endothelial dysfunction through an Axl-dependent mechanism. Cardiovasc Diabetol (2014) 0.98

Lentiviral-human heme oxygenase targeting endothelium improved vascular function in angiotensin II animal model of hypertension. Hum Gene Ther (2011) 0.92

Vascular endothelial growth factor inhibition by dRK6 causes endothelial apoptosis, fibrosis, and inflammation in the heart via the Akt/eNOS axis in db/db mice. Diabetes (2009) 0.92

Effects of some anti-diabetic and cardioprotective agents on proliferation and apoptosis of human coronary artery endothelial cells. Cardiovasc Diabetol (2012) 0.89

Hyperglycemia slows embryonic growth and suppresses cell cycle via cyclin D1 and p21. Diabetes (2012) 0.86

MiR-492 impairs the angiogenic potential of endothelial cells. J Cell Mol Med (2013) 0.86

Panax Quinquefolius Saponin of Stem and Leaf Attenuates Intermittent High Glucose-Induced Oxidative Stress Injury in Cultured Human Umbilical Vein Endothelial Cells via PI3K/Akt/GSK-3 β Pathway. Evid Based Complement Alternat Med (2013) 0.86

Acute hyperglycemia abolishes cardioprotection by remote ischemic perconditioning. Cardiovasc Diabetol (2015) 0.85

Impaired collateral recruitment and outward remodeling in experimental diabetes. Diabetes (2008) 0.85

Major determinants for the uncovered stent struts on optical coherence tomography after drug-eluting stent implantation. Int J Cardiovasc Imaging (2011) 0.83

High glucose attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/STAT3 signalling. J Cell Mol Med (2008) 0.83

Effect of hyperglycemia on human monocyte activation. J Investig Med (2011) 0.83

Hyperglycemia enhances function and differentiation of adult rat cardiac fibroblasts. Can J Physiol Pharmacol (2014) 0.83

Sphingosine-1-phosphate inhibits high glucose-mediated ERK1/2 action in endothelium through induction of MAP kinase phosphatase-3. Am J Physiol Cell Physiol (2008) 0.83

STAT1-mediated Bim expression promotes the apoptosis of retinal pericytes under high glucose conditions. Cell Death Dis (2014) 0.82

Phosphatidylinositol-3,4,5-triphosphate and cellular signaling: implications for obesity and diabetes. Cell Physiol Biochem (2015) 0.80

Role of phosphoinositide 3-kinase IA (PI3K-IA) activation in cardioprotection induced by ouabain preconditioning. J Mol Cell Cardiol (2015) 0.80

Hydrogen sulfide decreases high glucose/palmitate-induced autophagy in endothelial cells by the Nrf2-ROS-AMPK signaling pathway. Cell Biosci (2016) 0.79

The zebrafish/tumor xenograft angiogenesis assay as a tool for screening anti-angiogenic miRNAs. Cytotechnology (2014) 0.79

Tipping the balance from angiogenesis to fibrosis in CKD. Kidney Int Suppl (2011) (2014) 0.79

Effect of PIP3 on adhesion molecules and adhesion of THP-1 monocytes to HUVEC treated with high glucose. Cell Physiol Biochem (2014) 0.79

Short-term high glucose exposure impairs insulin signaling in endothelial cells. Cardiovasc Diabetol (2015) 0.78

Does hyperglycemia reduce proliferation or increase apoptosis? Am J Physiol Heart Circ Physiol (2006) 0.77

Down regulation of the proliferation and apoptotic pathways in the embryonic brain of diabetic rats. Cell Mol Neurobiol (2012) 0.76

Glucose-Induced Oxidative Stress Reduces Proliferation in Embryonic Stem Cells via FOXO3A/β-Catenin-Dependent Transcription of p21(cip1). Stem Cell Reports (2016) 0.76

Hyperglycemia attenuates angiogenic capability of survivin in endothelial cells. Microvasc Res (2009) 0.75

Inhibition of protein kinase C enhances angiogenesis induced by platelet-derived growth factor C in hyperglycemic endothelial cells. Cardiovasc Diabetol (2015) 0.75

Metabolites of flavonoid compounds preserve indices of endothelial cell nitric oxide bioavailability under glucotoxic conditions. Nutr Diabetes (2017) 0.75

High-density lipoproteins attenuate high glucose-impaired endothelial cell signaling and functions: potential implications for improved vascular repair in diabetes. Cardiovasc Diabetol (2017) 0.75

Articles cited by this

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (1998) 95.79

Diabetes and cardiovascular disease. The Framingham study. JAMA (1979) 11.95

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care (1999) 9.16

Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science (1997) 8.81

PI3K: downstream AKTion blocks apoptosis. Cell (1997) 7.73

Akt/protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol (2002) 3.68

Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci U S A (2000) 3.40

Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation (1999) 3.16

Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci U S A (2002) 3.08

Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation (2000) 2.59

Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation (1996) 2.19

(S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta. J Med Chem (1996) 1.77

Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions. Diabetologia (1996) 1.70

Endothelial atheroprotective and anti-inflammatory mechanisms. Ann N Y Acad Sci (2001) 1.66

Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin. J Biol Chem (2000) 1.50

Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications. Physiol Res (2005) 1.48

VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways. Microvasc Res (2001) 1.45

Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol (1997) 1.37

Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities. Diabetes (2001) 1.32

Mechanism of protein kinase B activation by insulin/insulin-like growth factor-1 revealed by specific inhibitors of phosphoinositide 3-kinase--significance for diabetes and cancer. Pharmacol Ther (1999) 1.14

Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: new insights on the pathophysiological mechanisms of diabetic vascular complications. In Vitro Cell Dev Biol (1993) 1.12

High glucose-mediated effects on endothelial cell proliferation occur via p38 MAP kinase. Am J Physiol Endocrinol Metab (2003) 1.09

Akt mediates insulin induction of glucose uptake and up-regulation of GLUT4 gene expression in brown adipocytes. FEBS Lett (2001) 1.08

Early growth response factor-1 mediates insulin-inducible vascular endothelial cell proliferation and regrowth after injury. J Cell Biochem (2001) 0.95

Pharmacotherapy for diabetic retinopathy. Curr Opin Ophthalmol (2004) 0.95

Activation of members of the mitogen-activated protein kinase family by glucose in endothelial cells. Am J Physiol Endocrinol Metab (2000) 0.95

AlphaB-crystallin inhibits glucose-induced apoptosis in vascular endothelial cells. Biochem Biophys Res Commun (2004) 0.95

Collateral circulation and diabetes. Circulation (1999) 0.92

A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition. Am J Kidney Dis (2003) 0.91

Intracellular mechanism of high D-glucose-induced modulation of vascular cell proliferation. Eur J Pharmacol (1995) 0.90

Antiproliferative effect of elevated glucose in human microvascular endothelial cells. J Cell Biochem (1998) 0.90

High glucose and endothelial cell growth: novel effects independent of autocrine TGF-beta 1 and hyperosmolarity. Am J Physiol Cell Physiol (2003) 0.89

Current perspectives on interventional treatment strategies in diabetic patients with coronary artery disease. Catheter Cardiovasc Interv (2000) 0.89

Angiogenic interaction between retinal endothelial cells and pericytes from normal and diabetic rabbits, and phenotypic changes of diabetic cells. Cell Mol Biol (Noisy-le-grand) (1999) 0.88

Protein kinase Cbeta selective inhibitor LY333531 attenuates diabetic hyperalgesia through ameliorating cGMP level of dorsal root ganglion neurons. Diabetes (2003) 0.88

Altered proliferative responses of dermal fibroblasts to TGF-beta1 may contribute to chronic venous stasis ulcer. J Vasc Surg (2003) 0.86

Human endothelial cells are defective in diabetic vascular disease. J Surg Res (1994) 0.85

Human retinal vascular cells differ from umbilical cells in synthetic functions and their response to glucose. Proc Soc Exp Biol Med (1992) 0.84

Reduction of high glucose and phorbol-myristate-acetate-induced endothelial cell permeability by protein kinase C inhibitors LY379196 and hypocrellin A. Biochem Pharmacol (2004) 0.84

Articles by these authors

Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57

Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey. Circulation (2007) 2.63

Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J Hum Genet (2006) 2.41

Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C. Hepatology (2013) 2.36

The Carotid Revascularization Endarterectomy versus Stenting Trial: credentialing of interventionalists and final results of lead-in phase. J Stroke Cerebrovasc Dis (2010) 2.35

Patterns of in-stent restenosis after carotid artery stenting: classification and implications for long-term outcome. J Vasc Surg (2007) 2.27

The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg (2011) 2.15

Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). J Am Coll Cardiol (2009) 2.08

Early outcome of folding mitral valve repair technique without resection for mitral valve prolapse in 60 patients. J Thorac Cardiovasc Surg (2012) 2.06

Guidelines for screening of extracranial carotid artery disease: a statement for healthcare professionals from the multidisciplinary practice guidelines committee of the American Society of Neuroimaging; cosponsored by the Society of Vascular and Interventional Neurology. J Neuroimaging (2007) 2.05

Functional significance of differential eNOS translocation. Am J Physiol Heart Circ Physiol (2006) 1.94

Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease. J Vasc Surg (2011) 1.92

HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology (2002) 1.92

Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS). Circ J (2009) 1.80

Acute type A dissection: conservative methods provide consistently low mortality. Ann Thorac Surg (2002) 1.75

Age and outcomes after carotid stenting and endarterectomy: the carotid revascularization endarterectomy versus stenting trial. Stroke (2011) 1.69

MDCT detection of double right coronary artery arising from a single ostium in the right sinus of Valsalva: report of 2 cases. Int J Cardiol (2006) 1.62

Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial). Circ J (2010) 1.58

Qualitative and quantitative changes in coronary plaque associated with atorvastatin therapy. Circ J (2009) 1.56

Does sex matter? Thirty-day stroke and death rates after carotid artery stenting in women versus men: results from the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) lead-in phase. Stroke (2009) 1.54

Carotid artery stenting: analysis of data for 105 patients at high risk. J Vasc Surg (2003) 1.53

Complement 3 is involved in the synthetic phenotype and exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension (2004) 1.51

VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am J Physiol Heart Circ Physiol (2002) 1.49

Aortic valve replacement in Behcet's disease: surgical modification to prevent valve detachment. Eur J Cardiothorac Surg (2009) 1.48

Diagnosis and invasive management of carotid atherosclerotic stenosis. Mayo Clin Proc (2007) 1.46

Comparison of coronary sinus morphology in patients with and without atrioventricular nodal reentrant tachycardia by intracardiac echocardiography. J Cardiovasc Electrophysiol (2004) 1.46

Multiple papillary fibroelastoma in left ventricle associated with obstructive hypertrophic cardiomyopathy. Interact Cardiovasc Thorac Surg (2009) 1.45

Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability. Microcirculation (2006) 1.44

The NO cascade, eNOS location, and microvascular permeability. Cardiovasc Res (2010) 1.43

Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound. JACC Cardiovasc Interv (2009) 1.43

Duplex ultrasound velocity criteria for the stented carotid artery. J Vasc Surg (2008) 1.43

Isolated noncompaction of the ventricular myocardium in a 94-year-old patient: depiction at echocardiography and magnetic resonance imaging. Int J Cardiol (2007) 1.41

Rupture of thoracoabdominal aortic aneurysm associated with Behcet's disease. Ann Thorac Surg (2007) 1.40

Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-beta1 promoter for treatment of progressive renal diseases. J Am Soc Nephrol (2005) 1.39

Intravascular ultrasound evaluation of ruptured plaque in the left main coronary artery misinterpreted as an aneurysm by angiography. Catheter Cardiovasc Interv (2004) 1.38

Carotid artery closure for endarterectomy does not influence results of angioplasty-stenting for restenosis. J Vasc Surg (2002) 1.38

Endothelial nitric oxide synthase regulates microvascular hyperpermeability in vivo. J Physiol (2006) 1.36

Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b. J Clin Virol (2012) 1.35

Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance. Circ Res (2008) 1.34

Management of atherosclerotic carotid artery disease: clinical practice guidelines of the Society for Vascular Surgery. J Vasc Surg (2008) 1.33

Carotid artery stenting: is there a need to revise ultrasound velocity criteria? J Vasc Surg (2004) 1.27

Acupuncture reduces experimental renovascular hypertension through mechanisms involving nitric oxide synthases. Microcirculation (2006) 1.26

Safety and feasibility of an intravascular optical coherence tomography image wire system in the clinical setting. Am J Cardiol (2008) 1.24

Vascular endothelial growth factor stimulates differential signaling pathways in in vivo microcirculation. Am J Physiol Heart Circ Physiol (2004) 1.20

Cardiac valvular surgery in dialysis patients: comparison of surgical outcome for mechanical versus bioprosthetic valves. Gen Thorac Cardiovasc Surg (2009) 1.19

Double left anterior descending artery arising from the left and right coronary arteries: depiction at multidetector-row computed tomography. Int J Cardiol (2007) 1.18

Management of mobile floating carotid plaque using carotid artery stenting. J Endovasc Ther (2003) 1.17

Microvascular permeability in diabetes and insulin resistance. Microcirculation (2007) 1.17

Cognitive changes after surgery vs stenting for carotid artery stenosis. J Vasc Surg (2011) 1.14

Internalization of eNOS and NO delivery to subcellular targets determine agonist-induced hyperpermeability. Proc Natl Acad Sci U S A (2009) 1.14

Endothelial Rho and Rho kinase regulate neutrophil migration via endothelial myosin light chain phosphorylation. J Leukoc Biol (2002) 1.14

Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: executive summary. J Vasc Surg (2011) 1.13

Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir. Hepatology (2011) 1.12

Dedifferentiated fat cells convert to cardiomyocyte phenotype and repair infarcted cardiac tissue in rats. J Mol Cell Cardiol (2009) 1.12

Involvement of H1 and H2 receptors and soluble guanylate cyclase in histamine-induced relaxation of rat mesenteric collecting lymphatics. Microcirculation (2014) 1.12

Pixel distribution analysis of B-mode ultrasound scan images predicts histologic features of atherosclerotic carotid plaques. J Vasc Surg (2002) 1.10

Completely pulsatile high flow circulatory support with a constant-speed centrifugal blood pump: mechanisms and early clinical observations. Gen Thorac Cardiovasc Surg (2007) 1.10

Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension. Am J Physiol Heart Circ Physiol (2006) 1.10

VE-cadherin and beta-catenin binding dynamics during histamine-induced endothelial hyperpermeability. Am J Physiol Cell Physiol (2008) 1.09

Primary chronic venous disorders. J Vasc Surg (2007) 1.08

Tumor-derived TGFbeta-1 induces dendritic cell apoptosis in the sentinel lymph node. J Immunol (2006) 1.07

Efficacy of multislice computed tomography for the detection of acute coronary syndrome in the emergency department. Circ J (2005) 1.07

Cooled-tip ablation results in increased radiofrequency power delivery and lesion size in the canine heart: importance of catheter-tip temperature monitoring for prevention of popping and impedance rise. J Interv Card Electrophysiol (2002) 1.05

A role for long chain myosin light chain kinase (MLCK-210) in microvascular hyperpermeability during severe burns. Shock (2007) 1.05

In-stent recurrent stenosis after carotid artery stenting: life table analysis and clinical relevance. J Vasc Surg (2003) 1.03

ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells. Exp Biol Med (Maywood) (2011) 1.03

p42/44MAPK regulates baseline permeability and cGMP-induced hyperpermeability in endothelial cells. Microvasc Res (2002) 1.03

Stroke after carotid stenting and endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Circulation (2012) 1.03

ACh-induced endothelial NO synthase translocation, NO release and vasodilatation in the hamster microcirculation in vivo. J Physiol (2002) 1.01

More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome--sub-analysis of JAPAN-ACS study. J Atheroscler Thromb (2010) 0.99

Myocardial fibrosis in a patient with apical hypertrophic cardiomyopathy detected by delayed-enhanced magnetic resonance imaging. Int J Cardiol (2007) 0.99

Sustained virological response in a patient with chronic hepatitis C treated by monotherapy with the NS3-4A protease inhibitor telaprevir. J Clin Virol (2009) 0.99

Internalization of eNOS via caveolae regulates PAF-induced inflammatory hyperpermeability to macromolecules. Am J Physiol Heart Circ Physiol (2008) 0.97

Adaptation of mesenteric collecting lymphatic pump function following acute alcohol intoxication. Microcirculation (2010) 0.97

Lymphorrhea responds to negative pressure wound therapy. J Vasc Surg (2007) 0.97

Criteria for defining significant central vein stenosis with duplex ultrasound. J Vasc Surg (2007) 0.96

Diagnosis of anomalous origin of the right coronary artery using multislice computed tomography: evaluation of possible causes of myocardial ischemia. Heart Vessels (2005) 0.96